Cargando…
Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations
Novel mechanistic insights are discussed herein that link a single, nontoxic, low-dose radiotherapy (LDRT) treatment (0.5–1.0 Gy) to (1) beneficial subcellular effects mediated by the activation of nuclear factor erythroid 2-related transcription factor (Nrf2) and to (2) favorable clinical outcomes...
Autores principales: | Calabrese, Edward J., Kozumbo, Walter J., Kapoor, Rachna, Dhawan, Gaurav, Lara, Pedro C., Giordano, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080499/ https://www.ncbi.nlm.nih.gov/pubmed/33932453 http://dx.doi.org/10.1016/j.radonc.2021.04.015 |
Ejemplares similares
-
Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS)()
por: Dhawan, Gaurav, et al.
Publicado: (2020) -
Radiotherapy for Pertussis: An Historical Assessment
por: Calabrese, Edward J., et al.
Publicado: (2017) -
Necrotizing Fasciitis: Low-Dose Radiotherapy as a Potential Adjunct
Treatment
por: Dhawan, Gaurav, et al.
Publicado: (2019) -
How Radiotherapy Was Historically Used To Treat Pneumonia: Could It
Be Useful Today?
por: Calabrese, Edward J., et al.
Publicado: (2013) -
Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants
por: Kapoor, Rachna, et al.
Publicado: (2021)